Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa for Anemia in Lung Cancer Patients Receiving Chemotherapy
NCT03776032Phase 3Completed
- Sponsor
- Amgen
- Start
- Sep 1999
- Primary completion
- Nov 2000
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
Phase 3, randomised, double-blind trial in anemia comparing Darbepoetin alfa with Placebo (2 arms). Primary endpoint: Percentage of Participants with a Red Blood Cell Transfusion During Weeks 5 to 12. Started Sep 1999; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03776032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03776032.